Candriam S.C.A. Sells 8,995 Shares of Synopsys, Inc. $SNPS

Candriam S.C.A. cut its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 18.8% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 38,905 shares of the semiconductor company’s stock after selling 8,995 shares during the period. Candriam S.C.A.’s holdings in Synopsys were worth $16,983,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in the stock. Kornitzer Capital Management Inc. KS grew its position in Synopsys by 96.7% during the third quarter. Kornitzer Capital Management Inc. KS now owns 3,979 shares of the semiconductor company’s stock valued at $1,731,000 after acquiring an additional 1,956 shares during the period. Pictet Asset Management Holding SA raised its holdings in shares of Synopsys by 90.8% in the 3rd quarter. Pictet Asset Management Holding SA now owns 1,132,130 shares of the semiconductor company’s stock worth $492,223,000 after purchasing an additional 538,737 shares during the period. Formidable Asset Management LLC lifted its stake in shares of Synopsys by 133.3% in the 3rd quarter. Formidable Asset Management LLC now owns 4,153 shares of the semiconductor company’s stock valued at $1,833,000 after purchasing an additional 2,373 shares in the last quarter. Tamar Securities LLC grew its holdings in shares of Synopsys by 0.9% during the 3rd quarter. Tamar Securities LLC now owns 54,453 shares of the semiconductor company’s stock worth $23,684,000 after purchasing an additional 488 shares during the period. Finally, United Advisor Group LLC increased its position in Synopsys by 57.6% during the 3rd quarter. United Advisor Group LLC now owns 1,291 shares of the semiconductor company’s stock worth $562,000 after purchasing an additional 472 shares in the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, insider Aart de Geus sold 24,641 shares of Synopsys stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $419.44, for a total transaction of $10,335,421.04. Following the sale, the insider directly owned 120,443 shares of the company’s stock, valued at approximately $50,518,611.92. The trade was a 16.98% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Sudhindra Kankanwadi sold 9,170 shares of the business’s stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total value of $4,585,000.00. Following the completion of the transaction, the chief financial officer owned 22,717 shares in the company, valued at approximately $11,358,500. This trade represents a 28.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 117,163 shares of company stock valued at $51,366,457 over the last ninety days. Insiders own 0.56% of the company’s stock.

Synopsys Stock Performance

SNPS opened at $450.46 on Monday. The firm’s 50 day moving average is $441.61 and its 200-day moving average is $442.27. Synopsys, Inc. has a 52-week low of $362.55 and a 52-week high of $539.48. The company has a quick ratio of 1.24, a current ratio of 1.34 and a debt-to-equity ratio of 0.29. The firm has a market capitalization of $86.33 billion, a P/E ratio of 79.59, a P/E/G ratio of 1.43 and a beta of 1.18.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The business had revenue of $2.48 billion during the quarter, compared to analyst estimates of $2.44 billion. During the same period last year, the business earned $3.39 EPS. The business’s revenue was up 42.4% on a year-over-year basis. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Analysts expect that Synopsys, Inc. will post 11.01 EPS for the current fiscal year.

Synopsys announced that its board has authorized a share repurchase program on Monday, October 5th that authorizes the company to repurchase $1 billion in outstanding shares. This buyback authorization authorizes the semiconductor company to repurchase up to 1.1% of its shares through open market purchases. Share buyback programs are often a sign that the company’s board believes its shares are undervalued.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on SNPS. Benchmark reaffirmed a “buy” rating and set a $570.00 price target on shares of Synopsys in a research report on Thursday, August 27th. Weiss Ratings lowered shares of Synopsys from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, September 11th. Rosenblatt Securities increased their price objective on shares of Synopsys from $575.00 to $620.00 and gave the stock a “buy” rating in a research report on Thursday, October 1st. UBS Group set a $570.00 target price on shares of Synopsys in a research note on Thursday, August 27th. Finally, Zacks Research upgraded shares of Synopsys from a “hold” rating to a “strong-buy” rating in a report on Friday, October 2nd. One equities research analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $575.00.

About Synopsys

Synopsys, Inc develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs.

The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.